✦ LIBER ✦

Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples

✍ Scribed by John F. Codington; Svein Haavik; Najmosama Nikrui; Irene Kuter; Christina Vassileva; Hui Zhang; Samantha Matson; Xiaomei Chen; Zibin Wu

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 154 KB
Volume: 94
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.10124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical, serologic, and immunologic eff

Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma

✍ Prem V. Nair; Myron J. Tong; Raymond Kempf; Ruth Co; Shou-Dong Lee; Cheryl L. Ve 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 1 views

Five patients with hepatitis B surface antigen (HBsAg) positive chronic hepatitis and histologically confirmed primary hepatocellular carcinoma (PHC) were treated with 3 X lo6 units/day of partially purified human leukocyte interferon intramuscularly for 2 consecutive months. During interferon thera

Expression of antigens immunologically r

Expression of antigens immunologically related to mouse mammary gland carcinoma virus antigens in human breast tumor tissue

✍ L. V. Remennik; S. V. Litvinov; I. N. Kryukova; Yu. V. Chuev 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 481 KB

Definition of the expression of the huma

Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas

✍ Paul F. Robbins; Diane Eggensperger; Chen-Feng Qi; Jeffrey Schlom 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 1018 KB

Mouse cell lines transfected with carcinoembryonic antigen (CEA) and with 2 other members of the human CEA gene family, non-specific cross-reacting antigen (NCA) and biliary glycoprotein (BGP), were used to analyze the specificity of several monoclonal antibodies (MAbs). MAbs COL-I and COL-6 were sh

Prostate carcinoma staging: Clinical uti

Prostate carcinoma staging: Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen

✍ Juan Morote; José Antonio Lorente; Gloria Encabo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

BACKGROUND. Biochemical markers of bone disease have been of interest as part of the investigation of prostate carcinoma and the monitoring of skeletal involvement. Bone isoenzyme of the alkaline phosphatase (BAP) is an indicator of the metabolism of the osteoblasts. An immunoradioanalyses with two

Purification of tumor-specific antigens.

Purification of tumor-specific antigens. An overview of the relevance to human colon carcinoma

✍ Dr. Barry D. Kahan; Baldwin H. Tom; Margalit B. Mokyr; Lynne P. Rutzky; Neal R. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

Methods which dissociate intramolecular noncovalent bonds have been used to prepare soluble derivatives of cell-surface antigens. Applications of these techniques to human colon carcinoma are underway. Continuous tissue-culture strains derived from primary lesions were developed and shown to be comp

The use of prostate specific antigen den

The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma

✍ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr